The Kratom Trade Association is the first and only kratom industry advocacy group in the United States. KTA’s mission is to support and promote the kratom industry with a range of strategies including education, public awareness campaigns, and research.
KTA has had a busy year so far, lending its support to consumers who rely on kratom in the face of potential bans on both state and federal levels. On the federal level, KTA has provided a powerful advocacy voice against House Resolution 6, which includes both the “Stop the Importation and Trafficking of Synthetic Analogues” (SITSA) Act and the “Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now” (SCREEN) Act. These Acts serve to curtail the availability of and importation of synthetic opioid analogs. Both Acts are a kneejerk response to several highly-publicized illness claims from tainted shipments of kratom and follow on a DEA proposal to ban the importation of kratom altogether. KTA will continue to provide support for consumer rights, helping to ensure that kratom will be available for American consumers.
Many state initiatives to limit or ban sales and possession of kratom have been proposed over the past year, and KTA has worked with state legislators and other advocates to protect consumer rights. In Louisiana, state legislators passed House Resolution 177, which directs the state Department of Health to create a study group that will ultimately determine if kratom should be a controlled drug within the state. The study group will review any available medical and scientific research on the effects and applications of kratom to make this determination. KTA has reached out to the Louisiana Department of Health to engage in discussions with the study group in advance of any reports the group might issue.
Georgia passed a similar resolution to study whether kratom should be classified as a dangerous drug in the state. Thanks to the advocacy support of KTA and forward-thinking legislators, a state Representative who is a strong kratom supporter was appointed to the study group. Representative Vernon Jones will help to provide a clear-headed voice to the group, stressing the importance of presenting the facts and science behind kratom.
Kratom advocates enjoyed a victory in the state of Tennessee. A statewide ban proposal was put forth, and with vocal support from patients, caregivers, and trade organizations like the KTA, Tennessee passed a law that removes kratom from the state list of banned substances. Kratom continues to be legal to possess and use for people age 21 and over, provided the kratom is in raw powdered or crushed leaf form. The Tennessee law also added package labeling requirements.
A similar victory was had in Kansas, when Governor Jeff Colyer signed into law SB 282, the Uniform Controlled Substances Act. Several legislators had pushed for a kratom ban within the state, and after a lengthy debate, kratom was ultimately removed from the state’s banned substances list. Kratom remains legal in Kansas.
In New York, Senate Bill S6924 was passed by state legislators in June and was referred to the state’s Health Committee. If the bill passes the next phase of legislation, it will effectively ban the sale of kratom – including raw plant material, preparations, and derivatives — to individuals under the age of 18. The bill would also impose civil penalties and fines for sales of kratom to people under the age of 18.
The Kratom Trade Association supports continued research into the effects of kratom. With solid science behind kratom and its potential medical applications, we believe that legislators will have the tools needed to make fair and just decisions regarding the future of kratom and its availability to American citizens.